Robot-Assisted Pelvic Dissection for Enlarged Lymph Nodes in Melanoma Improves Recovery with Equivalent Oncological Outcomes to Open Pelvic Dissection.

Journal: Annals of surgical oncology
PMID: 38177461

Abstract

BACKGROUND: Robot-assisted pelvic lymph node dissection (rPLND) has been reported in heterogenous groups of patients with melanoma, including macroscopic or at-high-risk-for microscopic metastasis. With changing indications for surgery in melanoma, and availability of effective systemic therapies, pelvic dissection is now performed for clinically detected bulky lymph node metastasis followed by adjuvant drug therapy. rPLND has not been compared with open pelvic lymph node dissection (oPLND) for modern practice.

Authors

  • Amit Roshan
    Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK. amit.roshan@cruk.cam.ac.uk.
  • Bhumi Shah
    School of Clinical Medicine, University of Cambridge, Cambridge, UK.
  • Keith D Anderson
    Department of Plastic Surgery, Cambridge University Hospitals NHS Trust, Cambridge, UK.
  • Suzanne Murphy
    Department of Plastic Surgery, Cambridge University Hospitals NHS Trust, Cambridge, UK.
  • Benjamin Thomas
    Department of Urology, The Royal Melbourne Hospital, Parkville, Victoria, Australia.
  • Arthur S McPhee
    Department of Urology, Cambridge University Hospitals NHS Trust, Cambridge, UK.
  • Benjamin W Lamb
    Urology Department, Addenbrooke's Hospital, Cambridge, UK.
  • Amer J Durrani
    Department of Plastic Surgery, Cambridge University Hospitals NHS Trust, Cambridge, UK.
  • Animesh J K Patel
    Department of Plastic Surgery, Cambridge University Hospitals NHS Trust, Cambridge, UK.

Keywords

External Resources

Popular Topics
Recent Journals